+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Retrovirus Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020

  • ID: 5230865
  • Report
  • November 2020
  • Region: Global
  • 85 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Akers Biosciences Inc
  • Biomedical Corporation
  • Biosciences Inc
  • Diagnostic Systems Inc
  • Diagnostics, Inc.
  • Group NV
  • MORE
Summary

The publisher's Medical Devices sector report, “Retrovirus Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Retrovirus Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Retrovirus Rapid Tests are the diagnostic tests used for rapid diagnosis, with immediate results to detect the antigen/antibody of HIV1, HIV 2 (human immunodeficiency virus) and HTLV I, HTLV II (human T-cell lymphotropic virus) viruses.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Retrovirus Rapid Tests & POC under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Retrovirus Rapid Tests & POC and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Retrovirus Rapid Tests & POC under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Akers Biosciences Inc
  • Biomedical Corporation
  • Biosciences Inc
  • Diagnostic Systems Inc
  • Diagnostics, Inc.
  • Group NV
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Retrovirus Rapid Tests & POC Overview

3 Products under Development
3.1 Retrovirus Rapid Tests & POC - Pipeline Products by Stage of Development
3.2 Retrovirus Rapid Tests & POC - Pipeline Products by Territory
3.3 Retrovirus Rapid Tests & POC - Pipeline Products by Regulatory Path
3.4 Retrovirus Rapid Tests & POC - Pipeline Products by Estimated Approval Date

4 Retrovirus Rapid Tests & POC - Pipeline Products under Development by Companies
4.1 Retrovirus Rapid Tests & POC Companies - Pipeline Products by Stage of Development
4.2 Retrovirus Rapid Tests & POC - Pipeline Products by Stage of Development

5 Retrovirus Rapid Tests & POC Companies and Product Overview
5.1 Akers Biosciences Inc Company Overview

6 Appendix
6.1 Methodology
6.2 About the Publisher
6.3 Contact
6.4 Disclaimer

List of Tables
Table 1: Retrovirus Rapid Tests & POC - Pipeline Products by Stage of Development
Table 2: Retrovirus Rapid Tests & POC - Pipeline Products by Territory
Table 3: Retrovirus Rapid Tests & POC - Pipeline Products by Regulatory Path
Table 4: Retrovirus Rapid Tests & POC - Pipeline Products by Estimated Approval Date
Table 5: Retrovirus Rapid Tests & POC Companies - Pipeline Products by Stage of Development
Table 6: Retrovirus Rapid Tests & POC - Pipeline Products by Stage of Development
Table 7: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 8: PIFA HIV 1+2 Rapid Assay - Product Status

List of Figures
Figure 1: Retrovirus Rapid Tests & POC - Pipeline Products by Stage of Development
Figure 2: Retrovirus Rapid Tests & POC - Pipeline Products by Territory
Figure 3: Retrovirus Rapid Tests & POC - Pipeline Products by Regulatory Path
Figure 4: Retrovirus Rapid Tests & POC - Pipeline Products by Estimated Approval Date
Note: Product cover images may vary from those shown
3 of 3
  • Akers Biosciences Inc
  • Biosciences Inc
  • Technologies Inc
  • Wantai Biological Pharmacy Enterprise Co Ltd
  • Health Inc
  • Group NV
  • Biomedical Corporation
  • International de Reference Chantal Biya
  • Diagnostic Systems Inc
  • Technologies Inc
  • Diagnostics, Inc.
  • Medical Institute LLC
Note: Product cover images may vary from those shown
Adroll
adroll